Cargando…

Share – Workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales:	Vastert, Sebastiaan, Boom, Victor, Ravelli, Angelo, Martini, Alberto, Foster, Helen, Wulffraat, Nico, Anton, Jordi, Constantin, Tamas, Dolezalova, Pavla, Horneff, Gerd, Lahdenne, Pekka, Magnussen, Bo, Minden, Kirsten, Nistala, Kiran, Quartier, Pierre, Rumbla, Ingrida, Ruperto, Nicola, Piccolo, Vanessa Remy, Russo, Ricardo, Uziel, Sefi, Wouters, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191152/ http://dx.doi.org/10.1186/1546-0096-12-S1-P171

Ejemplares similares

Share – Workpackage 4: addressing the need for health care for paediatric rheumatic diseases throughout europe
por: Dolezalova, Pavla, et al.
Publicado: (2014)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2014)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of the antiphospholipid syndrome
por: Groot, Noortje, et al.
Publicado: (2014)

SHARE – workpackage 5 : evidence based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus
por: Groot, Noortje, et al.
Publicado: (2014)

SHARE – workpackage 5: development of best practices of diagnosis and treatment for paediatric rheumatic diseases throughout Europe
por: Vastert, Sebastiaan, et al.
Publicado: (2014)

SHARE – workpackage 5: evidence-based recommendations for diagnosis and treatment of kawasaki disease and henoch schönlein purpura
por: de Graeff, Nienke, et al.
Publicado: (2014)

Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
por: Boom, V., et al.
Publicado: (2015)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis
por: Culpo, Roberta, et al.
Publicado: (2014)

Consensus-based recommendations for the management of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2017)

SHARE – workpackage 5: evidence-based recommendations for diagnosis and treatment of rare paediatric vasculitides
por: de Graeff, Nienke, et al.
Publicado: (2014)

TS-MME Workpackages
por: Vuillemin, V
Publicado: (2006)

Nearly 20% of children are not correctly classified according to current ilar classification in a PRINTO dataset of more than 12,000 juvenile idiopathic arthritis patients
por: Consolaro, Alessandro, et al.
Publicado: (2014)

Beam Dynamics Workpackage Sessions Summary
por: Schulte, Daniel
Publicado: (2004)

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis
por: Trincianti, Chiara, et al.
Publicado: (2021)

Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial
por: Ruperto, Nicola, et al.
Publicado: (2014)

Results from the ELAN-BDYN Workpackage in 2004
por: Schulte, Daniel
Publicado: (2005)

Educational initiatives and training for paediatric rheumatology in Europe
por: Foster, Helen E., et al.
Publicado: (2018)

Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
por: Ravelli, A, et al.
Publicado: (2014)

Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset
por: Ravelli, A, et al.
Publicado: (2014)

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
por: Quartier, P, et al.
Publicado: (2013)

Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study
por: Quartier, Pierre, et al.
Publicado: (2020)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients
por: Wulffraat, NM, et al.
Publicado: (2014)

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial
por: Foeldvari, Ivan, et al.
Publicado: (2019)

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study
por: Horneff, Gerd, et al.
Publicado: (2014)

Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey
por: Minoia, Francesca, et al.
Publicado: (2022)

A multinational study of the epidemiology, treatment and outcome of childhood arthritis (epoca study): preliminary data from 6,940 patients
por: Consolaro, Alessandro, et al.
Publicado: (2014)

Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
por: Malattia, Clara, et al.
Publicado: (2020)

Towards automation of computing fabrics using tools from the fabric management workpackage of the EU DataGrid project
por: Barring, Olof, et al.
Publicado: (2003)

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review
por: Horneff, Gerd, et al.
Publicado: (2023)

The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Wulffraat, Nico, et al.
Publicado: (2018)

Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
por: Bulatović, Maja, et al.
Publicado: (2011)

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study
por: Ruperto, N, et al.
Publicado: (2011)

Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
por: Ćalasan, Maja Bulatović, et al.
Publicado: (2012)

Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
por: Horneff, G, et al.
Publicado: (2015)

Time to share
por: Wulffraat, Nico M, et al.
Publicado: (2013)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

PReS-FINAL-1015: A systematic literature review on diagnosis and treatment of pediatric rheumatic diseases: a shared initiative
por: Boom, V, et al.
Publicado: (2013)

Epidemiology of JIA
por: Lahdenne, Pekka
Publicado: (2014)

Vasculitis
por: Dolezalova, Pavla
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i9v8l88mbmguhd0ff6hbmeg5n9